Arrowstreet Capital
HIMS icon

Arrowstreet Capital’s Hims & Hers Health HIMS Stock Holding History

Arrowstreet Capital’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-568,970
Closed -$28.4M – 1985
2025
Q2 		$28.4M Sell
568,970
-1,402,250
-71% -$63.4M 0.02% 577
2025
Q1 		$58.2M Sell
1,971,220
-4,332,982
-69% -$161M 0.05% 340
2024
Q4 		$152M Buy
6,304,202
+4,145,305
+192% +$103M 0.12% 158
2024
Q3 		$39.8M Buy
2,158,897
+2,070,438
+2,341% +$37.1M 0.03% 379
2024
Q2 		$1.79M Buy
+88,459
New +$1.47M ﹤0.01% 1104
2020
Q4 		– Sell
-100,994
Closed -$1.19M – 2393
2020
Q3 		$1.19M Buy
+100,994
New +$1.08M ﹤0.01% 1764

Other funds holding HIMS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Arrowstreet Capital's HIMS Position: Q3 2025 in Review

Arrowstreet Capital sold out of Hims & Hers Health (HIMS) in Q3 2025, closing a stake of 568,970 shares — an estimated $28.4M sold.

Arrowstreet Capital first reported a position in HIMS in Q3 2020 and held it in 6 quarters. The position peaked at $152M in Q4 2024. 512 funds tracked by Wall St. Rank hold HIMS as of Q3 2025.

  • Arrowstreet Capital reported no remaining Hims & Hers Health position as of Q3 2025 after selling out during the quarter.
  • Arrowstreet Capital sold 568,970 Hims & Hers Health shares in Q3 2025, an estimated $28.4M.
  • Arrowstreet Capital first reported a position in Hims & Hers Health in Q3 2020 and held it in 6 quarters.
  • Arrowstreet Capital's Hims & Hers Health position peaked at $152M in Q4 2024.
  • 512 funds tracked by Wall St. Rank held Hims & Hers Health as of Q3 2025.

Based on Arrowstreet Capital's 13F filing for Q3 2025, filed 13 Nov 2025.